Malignant hydatidiform mole
When the blister-like tissue of a hydatidiform mole exceeds the scope of the uterine cavity, invades the deep uterine myometrium or metastasizes to other parts, it is called a malignant hydatidiform mole. The chance of a hydatidiform mole turning into a malignant hydatidiform mole or choriocarcinoma is 5% to 20%, most of which occur within 6 months after the hydatidiform mole is removed, but some hydatidiform mole may turn into a malignant hydatidiform mole before it is expelled. Although a malignant hydatidiform mole has the characteristics of a malignant tumor, its treatment effect and prognosis are better than those of choriocarcinoma.
-
Site of disease:
Uterus -
Infectious :
Not contagious -
Frequent population:
It is more common in people under 20 years old and over 40 years old... -
Related symptoms:
Internal bleeding stomach ache uterine perforation uterine bleeding uterine bleeding -
Concurrent disease:
Related Drugs
Xinfumectin Injection
Indication: Used for malignant hydatidiform mole, choriocarcinoma, and malignant lymphoma.
Manufacturer:
Fuzhou FU Yao Pharmaceutical Co., Ltd.
Xinfumectin Injection
Indication: Used for malignant hydatidiform mole, choriocarcinoma, and malignant lymphoma.
Manufacturer:
Fuzhou FU Yao Pharmaceutical Co., Ltd.
Fluorouracil Glucose Injection
Indication: Used for intracavitary chemotherapy of breast cancer, gastrointestinal cancer, malignant hydatidiform mole, serous cavity cancerous effusion, bladder cancer, etc.
Manufacturer:
Shandong Hualu Pharmaceutical Co., Ltd.
Adrenaline hydrazone tablets
Indication: It is suitable for bleeding caused by capillary damage and increased permeability, such as epistaxis, retinal hemorrhage, hemoptysis, gastrointestinal bleeding, hematuria, hemorrhoids and uterine bleeding, etc. It is also used for thrombocytopenic purpura, but the hemostatic effect is not very ideal.
Related Ingredients